pubmed-article:8999672 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:8999672 | lifeskim:mentions | umls-concept:C0019163 | lld:lifeskim |
pubmed-article:8999672 | lifeskim:mentions | umls-concept:C0337816 | lld:lifeskim |
pubmed-article:8999672 | lifeskim:mentions | umls-concept:C0008976 | lld:lifeskim |
pubmed-article:8999672 | lifeskim:mentions | umls-concept:C0042210 | lld:lifeskim |
pubmed-article:8999672 | lifeskim:mentions | umls-concept:C1274040 | lld:lifeskim |
pubmed-article:8999672 | lifeskim:mentions | umls-concept:C2587213 | lld:lifeskim |
pubmed-article:8999672 | pubmed:issue | 4 | lld:pubmed |
pubmed-article:8999672 | pubmed:dateCreated | 1997-1-23 | lld:pubmed |
pubmed-article:8999672 | pubmed:abstractText | Two yeast recombinant vaccines were compared: the Russian hepatitis B Combiotech vaccine in a dose of 20 mg and the Recombivax-HB vaccine in a dose of 10 mg manufactured in the USA (Merk, Sharp and Dohme Ltd.). Both agents were found safe and low reactogenic. After a course of 3 vaccinations with the Russian vaccine 92.5 to 97.5% subjects vaccinated after the 0-1-2 months and 0-1-6 months protocols had high levels of specific antibodies. In the group vaccinated with the American vaccine, antibodies to HBsAg were found in the sera of 95 to 100% subjects. These results demonstrate high immunological activity of both Russian and American vaccines. | lld:pubmed |
pubmed-article:8999672 | pubmed:language | rus | lld:pubmed |
pubmed-article:8999672 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:8999672 | pubmed:citationSubset | IM | lld:pubmed |
pubmed-article:8999672 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:8999672 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:8999672 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:8999672 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:8999672 | pubmed:issn | 0507-4088 | lld:pubmed |
pubmed-article:8999672 | pubmed:author | pubmed-author:BorisovaV NVN | lld:pubmed |
pubmed-article:8999672 | pubmed:author | pubmed-author:PavlovaL ILI | lld:pubmed |
pubmed-article:8999672 | pubmed:author | pubmed-author:IakovlevaI... | lld:pubmed |
pubmed-article:8999672 | pubmed:author | pubmed-author:GorbunovM AMA | lld:pubmed |
pubmed-article:8999672 | pubmed:author | pubmed-author:Krasil'nikovI... | lld:pubmed |
pubmed-article:8999672 | pubmed:author | pubmed-author:SkvortsovS... | lld:pubmed |
pubmed-article:8999672 | pubmed:author | pubmed-author:Lytsar'B NBN | lld:pubmed |
pubmed-article:8999672 | pubmed:author | pubmed-author:NoskovaA VAV | lld:pubmed |
pubmed-article:8999672 | pubmed:author | pubmed-author:TitovI AIA | lld:pubmed |
pubmed-article:8999672 | pubmed:author | pubmed-author:BeliakovaE... | lld:pubmed |
pubmed-article:8999672 | pubmed:author | pubmed-author:BudanovM VMV | lld:pubmed |
pubmed-article:8999672 | pubmed:author | pubmed-author:Bel'chenkoA... | lld:pubmed |
pubmed-article:8999672 | pubmed:author | pubmed-author:KorovinIu... | lld:pubmed |
pubmed-article:8999672 | pubmed:issnType | Print | lld:pubmed |
pubmed-article:8999672 | pubmed:volume | 41 | lld:pubmed |
pubmed-article:8999672 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:8999672 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:8999672 | pubmed:pagination | 170-2 | lld:pubmed |
pubmed-article:8999672 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
pubmed-article:8999672 | pubmed:meshHeading | pubmed-meshheading:8999672-... | lld:pubmed |
pubmed-article:8999672 | pubmed:meshHeading | pubmed-meshheading:8999672-... | lld:pubmed |
pubmed-article:8999672 | pubmed:meshHeading | pubmed-meshheading:8999672-... | lld:pubmed |
pubmed-article:8999672 | pubmed:meshHeading | pubmed-meshheading:8999672-... | lld:pubmed |
pubmed-article:8999672 | pubmed:meshHeading | pubmed-meshheading:8999672-... | lld:pubmed |
pubmed-article:8999672 | pubmed:meshHeading | pubmed-meshheading:8999672-... | lld:pubmed |
pubmed-article:8999672 | pubmed:articleTitle | [Russian recombinant vaccine against hepatitis B (results of controlled trials)]. | lld:pubmed |
pubmed-article:8999672 | pubmed:publicationType | Journal Article | lld:pubmed |
pubmed-article:8999672 | pubmed:publicationType | Clinical Trial | lld:pubmed |
pubmed-article:8999672 | pubmed:publicationType | English Abstract | lld:pubmed |
pubmed-article:8999672 | pubmed:publicationType | Randomized Controlled Trial | lld:pubmed |